Why Mobia Medical, Inc.’s (MOBI) Stock Is Up 5.20%
As of Wednesday, September 02, Mobia Medical, Inc.’s MOBI share price has surged by 5.20%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Commentary & Analysis
Why Mobia Medical, Inc.’s (MOBI) Stock Is Up 5.20%
As of Tuesday, September 01, Mobia Medical, Inc.’s MOBI share price has surged by 5.20%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Mobia Medical, Inc.’s (MOBI) Stock Is Up 6.27%
As of Friday, August 28, Mobia Medical, Inc.’s MOBI share price has surged by 6.27%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Mobia Medical, Inc.’s (MOBI) Stock Is Up 6.76%
As of Wednesday, August 12, Mobia Medical, Inc.’s MOBI share price has surged by 6.76%, which has investors questioning if this is right time to sell.Jenna Brashear
What You Need to Know About Mobia Medical, Inc.'s Q3 Earnings
Mobia Medical, Inc.'s fiscal Q3 earnings report was released on Tuesday, August 11. Let's dive in to see if (MOBI) missed or beat analyst's expectations.Jenna Brashear
Financial Summary
| Share Statistics | MOBI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $387.2 | $423.0 | 34% |
|
| Shares Out (Mil) | 19.1 | 41.5 | 29% |
|
| Institutional Ownership | 81.6% | 83.6% | 50% |
|
| Float (Mil) | 13.8 | 35.5 | 23% |
|
| Beta | na | 0.88 | na |
|
| Avg Daily Volume (000s) | 214 | 346 | 47% |
|
| Price Change (52-week) |
na | 65.4% | na |
|
| Growth | MOBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.461) | ($2.949) | ($2.204) | |
| Month Ago EPS | ($0.440) | ($2.501) | ($2.170) | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | ($0.442) | ($2.317) | ($2.143) | |
| Year/Year Chg | (58.2%) | (85.7%) | (89.4%) | |
| Financials | MOBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $45 | $119 | 19% |
|
| Net Income (TTM) (Mil) | ($64) | ($9) | 14% |
|
| EPS (TTM) | ($9.345) | ($0.400) | 5% |
|
| Operating Cash Flow (TTM) (Mil) | ($58) | ($3) | 9% |
|
| Net Cash Flow (TTM) (Mil) | $155 | $1 | 81% |
|
| Long-Term Debt (Q1) (Mil) | $8 | $23 | 27% |
|
| Enterprise Value (Q1) (Mil) | $197 | $376 | 26% |
|
| Valuation | MOBI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.24 | 2.85 | 54% |
|
| P/E | na | 27.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | MOBI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 81.7% | 58.5% | 90% |
|
| Net Margin | (141.6%) | (6.9%) | 6% |
|
| ROA | (65.7%) | (13.3%) | 9% |
|
| ROE | (74.3%) | (13.3%) | 12% |
|
| Liabilities to Assets | 11.6% | 46.0% | 7% |
|
| F-Score | 1 | 4 | na |
|
Mobia Medical, Inc. did not pass any screens on 9/4/2026.
